Insider Transactions in Q4 2020 at Accelerate Diagnostics, Inc (AXDX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2020
|
Jack Phillips Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,542
-28.75%
|
$10,794
$7.37 P/Share
|
|
Dec 17
2020
|
Ron Price Head of Commercial Operations |
SELL
Open market or private sale
|
Direct |
727
-27.95%
|
$5,089
$7.37 P/Share
|
|
Dec 17
2020
|
Steven Reichling Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
859
-5.22%
|
$6,013
$7.37 P/Share
|
|
Dec 16
2020
|
Jack Phillips Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,363
+50.0%
|
-
|
|
Dec 16
2020
|
Ron Price Head of Commercial Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,601
+50.0%
|
-
|
|
Dec 16
2020
|
Steven Reichling Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,142
+16.04%
|
-
|
|
Nov 09
2020
|
Steven Reichling Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
39,329
-74.73%
|
$353,961
$9.5 P/Share
|
|
Nov 09
2020
|
Steven Reichling Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
39,329
+42.77%
|
$78,658
$2.98 P/Share
|